COST-EFFECTIVENESS CONSEQUENCES OF OBESITY IN T2DM BY INSULIN ANALOGUE THERAPY

被引：0
|
作者：
Jozsa, Z. [1 ]
Toth, E. [2 ]
Nagy, B. [2 ]
机构：
[1] Novo Nordisk Hungary Ltd, Budapest, Hungary
[2] Healthware Ltd, Budapest, Hungary
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)72090-3
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A289 / A289
页数：1
相关论文
共 50 条
  • [41] INDIRECT COST-EFFECTIVENESS ANALYSIS OF EMPAGLIFLOZIN COMPARED TO CANAGLIFLOZIN FOR PATIENTS WITH T2DM AND CARDIOVASCULAR DISEASE IN THE SPANISH NATIONAL HEALTH SERVICE
    Carrasco Perez, M.
    Male, N.
    Serra Burriel, M.
    Pfarr, E.
    Kansal, A.
    VALUE IN HEALTH, 2018, 21 : S130 - S130
  • [42] Targeting two pathways to treat obesity and T2DM
    Claire Greenhill
    Nature Reviews Endocrinology, 2019, 15 : 4 - 4
  • [43] Effect of Obesity & T2DM on Cardiac Strain in Youth
    Haley, Jessica E.
    Gao, Zhiqian
    Khoury, Philip
    Stewart, Stephanie N.
    Madsen, Nicolas L.
    Kimball, Thomas R.
    Dolan, Lawrence M.
    Urbina, Elaine M.
    CIRCULATION, 2017, 135
  • [44] Targeting two pathways to treat obesity and T2DM
    Greenhill, Claire
    NATURE REVIEWS ENDOCRINOLOGY, 2018, 15 (01) : 4 - 4
  • [45] COST-EFFECTIVENESS OF A FLASH GLUCOSE MONITORING SYSTEM BASED ON REAL-WORLD USAGE FOR TYPE 2 DIABETES (T2DM) PATIENTS USING INTENSIVE INSULIN: A SWEDISH PERSPECTIVE
    Bilir, S. P.
    Spwehler, E. A.
    Hellmund, R.
    Munakata, J.
    VALUE IN HEALTH, 2017, 20 (09) : A587 - A587
  • [46] Rationale for exercise in T2DM patients with depression and/or obesity
    Kavookjian, Jan
    DIABETES, 2008, 57 : A305 - A305
  • [47] Gut microbial metabolites in obesity, NAFLD and T2DM
    Emanuel E. Canfora
    Ruth C. R. Meex
    Koen Venema
    Ellen E. Blaak
    Nature Reviews Endocrinology, 2019, 15 : 261 - 273
  • [48] Gut microbial metabolites in obesity, NAFLD and T2DM
    Canfora, Emanuel E.
    Meex, Ruth C. R.
    Venema, Koen
    Blaak, Ellen E.
    NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (05) : 261 - 273
  • [49] Insulin resistance of protein anabolism relates to greater gluconeogenesis in obesity and type 2 diabetes (T2DM)
    Morais, Jose A.
    Chevalier, Stephanie
    Burgess, Shawn C.
    Marliss, Errol B.
    Gougeon, Rejeanne
    DIABETES, 2008, 57 : A368 - A368
  • [50] Basal insulin persistence in Brazilian participants with T2DM
    Franco, Denise Reis
    Perez-Nieves, Magaly
    Ivanova, Jasmina I.
    Cao, Dachuang
    Caselato Vaz, Marcela Saturnino
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (10): : 1254 - 1264
12345